Dr. Daniel Portik joined the EORTC in May 2022 as an Emmanuel van der Schueren Radiotherapy Quality Assurance Fellow. Daniel received his medical degree at George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş (UMPhST), Romania. He has participated in several exchange programs in countries like Hungary, Indonesia and Sweden. He finished his radiation oncology training at the ‘Prof.Dr.Ion Chiricuta’ Oncology Institute, Cluj-Napoca, Romania in 2019. During his stay at EORTC Daniel will analyse the radiotherapy quality assurance for H&N trials such as EORTC 1420 ‘Best of’ and the EORTC-1219 DAHANCA trials. With a strong interest in the oligometastatic disease, he will participate in the RTQA of the ongoing EORTC 1702 HALT trial. Likewise, he will also assist in the development and testing of knowledge-based planning models within EORTC. Daniel’s fellowship is supported by the Kom op Tegen Kanker foundation.